Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	831.06	901.23	1,269	951.78	774.39	1,849
Trading Asset Securities	894.92	877.25	651.14	2,024	2,130	408.03
Cash & Short-Term Investments	1,726	1,778	1,920	2,975	2,904	2,257
Cash Growth	-13.75%	-7.39%	-35.46%	2.45%	28.69%	-0.54%
Accounts Receivable	468.71	352.76	208.35	192.17	136.29	182.61
Other Receivables	7.81	8.56	7.47	3.99	32	20.38
Receivables	476.52	361.32	215.82	196.16	168.29	202.98
Inventory	303.74	334.74	248.02	270.55	345.75	247.95
Prepaid Expenses	-	0.14	2.56	1.21	0.41	0.97
Other Current Assets	357.19	177.77	149.21	45.19	38.23	25.36
Total Current Assets	2,863	2,652	2,536	3,489	3,457	2,734
Property, Plant & Equipment	904.53	915.18	862.22	802.08	464.13	343.6
Long-Term Investments	234.28	972.71	1,030	371.85	358.34	261.19
Goodwill	758.1	757.87	642.68	451.3	323.45	323.85
Other Intangible Assets	392.87	402.3	367.73	312.35	241.62	214.6
Long-Term Deferred Tax Assets	66.67	66.01	51.67	30.52	35.43	47.23
Long-Term Deferred Charges	6.33	6.72	5.69	5.46	0.5	1.27
Other Long-Term Assets	604.24	14.24	29.18	26.91	19.53	16.89
Total Assets	5,830	5,787	5,526	5,489	4,900	3,943
Accounts Payable	466.78	427.6	390.98	485.06	431.57	448.09
Accrued Expenses	66.79	228.65	235.15	245.6	196.05	184.35
Short-Term Debt	10.01	10.01	6.01	10.01	-	25
Current Portion of Leases	-	5.76	3.42	5.48	1.65	-
Current Income Taxes Payable	51.88	35.21	35.8	28.68	48.01	40.3
Current Unearned Revenue	85.13	151.98	111.81	232.84	362.05	247.82
Other Current Liabilities	286.33	163.2	158.51	176.81	104.17	98.8
Total Current Liabilities	966.91	1,022	941.66	1,184	1,144	1,044
Long-Term Leases	7.02	7.43	8.69	10.67	4.32	-
Long-Term Unearned Revenue	22.35	23.17	28.62	32.88	32.18	32.65
Long-Term Deferred Tax Liabilities	50.86	52.51	46.99	43.59	25.9	29.43
Other Long-Term Liabilities	64.49	63.81	59.75	69.03	55.18	51.65
Total Liabilities	1,122	1,169	1,086	1,341	1,261	1,158
Common Stock	317.95	317.95	317.95	317.95	317.07	317.07
Additional Paid-In Capital	1,978	1,977	1,987	1,995	1,913	1,876
Retained Earnings	2,329	2,219	2,015	1,751	1,309	584.29
Treasury Stock	-167.2	-140.2	-99.74	-98.07	-	-
Comprehensive Income & Other	-2.24	-2.69	10.37	53.89	84.34	-1.01
Total Common Equity	4,456	4,372	4,231	4,021	3,623	2,776
Minority Interest	252.55	246.59	209.25	127.71	15.95	8.64
Shareholders' Equity	4,709	4,618	4,440	4,148	3,639	2,785
Total Liabilities & Equity	5,830	5,787	5,526	5,489	4,900	3,943
Total Debt	27.03	23.2	18.11	26.15	5.97	25
Net Cash (Debt)	1,699	1,755	1,902	2,949	2,898	2,232
Net Cash Growth	-14.26%	-7.73%	-35.50%	1.76%	29.86%	-1.64%
Net Cash Per Share	5.37	5.55	6.00	9.28	9.12	6.85
Filing Date Shares Outstanding	314.28	314.48	315.68	316.49	317.07	317.07
Total Common Shares Outstanding	314.28	314.48	316.47	316.49	317.07	317.07
Working Capital	1,897	1,630	1,594	2,304	2,313	1,690
Book Value Per Share	14.18	13.90	13.37	12.70	11.43	8.75
Tangible Book Value	3,305	3,211	3,220	3,257	3,058	2,237
Tangible Book Value Per Share	10.52	10.21	10.18	10.29	9.64	7.06
Buildings	-	696.63	649.88	257.73	243.72	230.31
Machinery	-	333.52	284.75	240.79	151.04	122.68
Construction In Progress	-	95.03	70.33	389.34	130.96	32.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.